Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiology of Fabry disease in patients in hemodialysis in the Madrid community.
Corchete Prats E, González-Parra E, Vega A, Macías N, Delgado M, Fernández M, Sánchez RJ, Álvarez L, Miranda RJ, Vian J, López V, Mérida E, Pereira M, Sapiencia D, Andrés N, Muñoz P, Gil Y, Sánchez M, Cases C, Gil B, García A, Sainz V, Alexandru S, Pampa S, López M, Flor JC, Estrada PN, Berlanga JR, Zamora R, Sánchez R, Rodríguez-Osorio L, Fraile C, Caravaca-Fontán F, Moratilla C, Cabré C, Furaz K, Nieto L, Villaverde MT, Tapia CG, Cedeño S, Castellano S, Valdés E, Ferreira M, Martínez P, Sanz M, Sánchez M, Ríos F, Palomo S, Serrano ML, Blanco A, Espinel L, Tornero F, Herrero JA. Corchete Prats E, et al. Among authors: moratilla c. Nefrologia (Engl Ed). 2023 Jul-Aug;43(4):435-441. doi: 10.1016/j.nefroe.2022.03.008. Epub 2022 Dec 21. Nefrologia (Engl Ed). 2023. PMID: 36564230 Free article.
Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: a randomized controlled trial.
Aragoncillo I, Abad S, Caldés S, Amézquita Y, Vega A, Cirugeda A, Moratilla C, Ibeas J, Roca-Tey R, Fernández C, Macías N, Quiroga B, Blanco A, Villaverde M, Ruiz C, Martín B, Ruiz AM, Ampuero J, de Alvaro F, López-Gómez JM. Aragoncillo I, et al. Among authors: moratilla c. J Vasc Access. 2017 Jul 14;18(4):352-358. doi: 10.5301/jva.5000700. Epub 2017 Apr 20. J Vasc Access. 2017. PMID: 28430315 Clinical Trial.
The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trial.
Aragoncillo I, Amézquita Y, Caldés S, Abad S, Vega A, Cirugeda A, Moratilla C, Ibeas J, Roca-Tey R, Fernández C, Quiroga B, Blanco A, Villaverde M, Ruiz C, Martín B, Ruiz AM, Ampuero J, López-Gómez JM, de Alvaro F. Aragoncillo I, et al. Among authors: moratilla c. J Vasc Access. 2016 Jan-Feb;17(1):13-9. doi: 10.5301/jva.5000461. Epub 2015 Sep 18. J Vasc Access. 2016. PMID: 26391583 Clinical Trial.
Pulmonary diffusing capacity in chronic dialysis patients.
Herrero JA, Alvarez-Sala JL, Coronel F, Moratilla C, Gámez C, Sánchez-Alarcos JM, Barrientos A. Herrero JA, et al. Among authors: moratilla c. Respir Med. 2002 Jul;96(7):487-92. doi: 10.1053/rmed.2002.1346. Respir Med. 2002. PMID: 12194631 Free article.
High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
Carrillo J, Martínez P, Solera J, Moratilla C, González A, Manguán-García C, Aymerich M, Canal L, Del Campo M, Dapena JL, Escoda L, García-Sagredo JM, Martín-Sala S, Rives S, Sevilla J, Sastre L, Perona R. Carrillo J, et al. Among authors: moratilla c. Blood Cells Mol Dis. 2012 Oct 15-Dec 15;49(3-4):140-6. doi: 10.1016/j.bcmd.2012.05.008. Epub 2012 Jun 2. Blood Cells Mol Dis. 2012. PMID: 22664374
Spanish study of anticoagulation in haemodialysis.
Herrero-Calvo JA, González-Parra E, Pérez-García R, Tornero-Molina F; Grupo de Estudio Español Sobre Anticoagulación en Hemodiálisis. Herrero-Calvo JA, et al. Nefrologia. 2012;32(2):143-52. doi: 10.3265/Nefrologia.pre2011.Nov.11106. Epub 2012 Jan 27. Nefrologia. 2012. PMID: 22425796 Free article. English, Spanish.
[Vascular access models cause heterogeneous results in the centres of one community].
Gruss E, Portolés J, Caro P, Merino JL, López-Sánchez P, Tato A, Rubio E, Vigil A, Albalate M, Hernández J, Fernández M, Sanz P; Grupo de Estudio del Acceso Vascular (AVE). Gruss E, et al. Nefrologia. 2010;30(3):310-6. doi: 10.3265/Nefrologia.pre2010.Apr.10359. Epub 2010 Apr 14. Nefrologia. 2010. PMID: 20414327 Free article. Spanish.
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R. Ibanez de Caceres I, et al. Among authors: moratilla c. Oncogene. 2010 Mar 18;29(11):1681-90. doi: 10.1038/onc.2009.454. Epub 2009 Dec 21. Oncogene. 2010. PMID: 20023704
MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, Cejas P, Machado-Pinilla R, Manguan-García C, Sánchez-Pérez I, Nistal M, Moratilla C, de Castro-Carpeño J, Gonzalez-Barón M, Albanell J, Perona R. Cortes-Sempere M, et al. Among authors: moratilla c. Cancer Lett. 2009 Dec 28;286(2):206-16. doi: 10.1016/j.canlet.2009.05.029. Epub 2009 Jun 23. Cancer Lett. 2009. PMID: 19553005
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S, Machado-Pinilla R, Manguan-García C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeño J, Casado E, Nistal M, Gonzalez-Barón M, Perona R. Chattopadhyay S, et al. Among authors: moratilla c. Oncogene. 2006 Jun 1;25(23):3335-45. doi: 10.1038/sj.onc.1209364. Epub 2006 Feb 6. Oncogene. 2006. PMID: 16462770
14 results